Despite concerns expressed by some experts, common high blood pressure medications did not increase the risk of contracting 2019 coronavirus disease (COVID-19)—or of developing severe disease—in a study of 12,594 patients.
Published online May 1 in the New England Journal of Medicine, the study was launched in response to a March 17 joint statement issued by the American Heart Association, the American College of Cardiology, and the Heart Failure Society of America. It urgently called for research to answer a question raised by past studies: do high blood pressure (antihypertensive) medications worsen COVID-19 patient outcomes?